Modification of Rhodamine Staining Allows Identification of Hematopoietic Stem Cells with Preferential Short-Term Or Long-Term Bone Marrow-Repopulating Ability J
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Increased Mitochondrial Uptake of Rhodamine 123 During Lymphocyte Stimulation
Proc. Natl. Acad. Sci. USA Vol. 78, No. 4, pp. 2383-2387, April 1981 Cell Biology Increased mitochondrial uptake of rhodamine 123 during lymphocyte stimulation (flow cytometry/cycling-noncycling cells/supravital fluorescent probe) ZBIGNIEW DARZYNKIEWICZ, LISA STAIANO-COICO, AND MYRON R. MELAMED Memorial Sloan-Kettering Cancer Center, New York, New York 10021 Communicated by Lloyd J. Old, January 5, 1981 ABSTRACT The positively charged rhodamine analog rho- trifugation on Ficoll/Isopaque (Lymphoprep; Nyegaardo, Oslo, damine 123 accumulates specifically in the mitochondria of living Norway). The mononuclear cells were suspended in Eagle's cells. In the present work, the uptake of rhodamine 123 by indi- basal medium containing 15% fetal bovine serum and subcul- vidual lymphocytes undergoing blastogenic transformation in cul- tured in plastic dishes to remove most ofthe monocytes (3). The tures stimulated by phytohemagglutinin was measured by flow nonadhering cells were then suspended in Eagle's medium con- cytometry. A severalfold increase in cell ability to accumulate rho- taining penicillin, streptomycin, and 15% fetal bovine serum damine 123 was observed during lymphocyte stimulation. Maxi- and incubated at 37°C in the presence of PHA (phytohemag- mal dye uptake, seen on the third day ofcell stimulation, coincided glutinin M, GIBCO) as described (2, 3). The samples were with- in time with the peak of DNA synthesis (maximal number of cells drawn from these cultures at daily intervals. Other details ofthe in the S phase) and mitotic activity. A large intercellular variation are elsewhere 3). among stimulated lymphocytes, with some cells having fluores- cell culture system given (2, cence increased as much as 15 times in comparison with nonstim- Cell Staining. -
Reversal of Resistance to Rhodamine 123 in Adriamycin-Resistant Friend Leukemia Cells1
[CANCER RESEARCH 45, 2626-2631, June 1985] Reversal of Resistance to Rhodamine 123 in Adriamycin-resistant Friend Leukemia Cells1 Theodore J. Lampidis,2 Jean-Nicolas Munck, Awtar Krishan, and Haim Tapiero Department of Oncology, University of Miami, School of Medicine, Comprehensive Cancer Center for the State of Florida, Miami, Florida 33101 [T. J. L, A. K.], and Departement de Pharmacologie Cellulaire, Moléculaireet de Pharmacocinétique, ICIG (CNRS LA-149), Hôpital Paul-Brousse, 94804 Villejuif, France [J-N. M., H. T.] ABSTRACT the calcium transport inhibitor, verapamil, on the cellular accu mulation and retention of Rho-123 and ADM as it relates to Pleiotropic resistance to rhodamine 123 (Rho-123) in Adria- resistance in these cell variants. mycin (ADM)-resistant Friend leukemia cells was circumvented by cotreatment with 10 //M verapamil. Increased cytotoxicity corresponded to higher intracellular Rho-123 levels. The vera- MATERIALS AND METHODS pamil-induced increase of drug accumulation in resistant cells is Cells and Cytotoxicity Assay. FLC were derived from a clone of accounted for at least in part by the blockage or slowing of Rho- Friend virus-tranformed 745A cells. Cells were seeded and grown as 123 efflux from these cells. In contrast, accumulation and con described previously (8). The cell variant resistant to ADM (ADM-RFLC3) sequent cytotoxicity of Rho-123 in sensitive cells are not in was derived from the above clone by continuous exposure to ADM (8). creased by verapamil. Similar results were obtained when ADM Resistant cells, grown for more than 150 passages in drug-free medium, was used in this cell system. -
(12) United States Patent (10) Patent No.: US 7476,504 B2 Turner (45) Date of Patent: Jan
USOO7476504B2 (12) United States Patent (10) Patent No.: US 7476,504 B2 Turner (45) Date of Patent: Jan. 13, 2009 (54) USE OF REVERSIBLE EXTENSION Glatthar, Ralf, et al. 2000. A New Photocleavable Linker in Solid TERMINATOR IN NUCLECACD Phase Chemistry for Ether Cleavage. Org. Lett. 2(15): 2315-2317. SEQUENCING Goldmacher, Victor S., et al. 1992. Photoactivation of Toxin Conju gates. Bioconjugate Chem. 3(2): 104-107. Guillier, Fabrice, et al. 2000. Linkers and Cleavage Strategies in (75) Inventor: Stephen Turner, Menlo Park, CA (US) Solid-Phase Organic Synthesis and Combinatorial Chemistry. Chem. Rev. 100(6): 2091-2157. (73) Assignee: Pacific Biosciences of California, Inc., Holmes, Christopher P. 1997. Model Studies for New o-Nitrobenzyl Menlo Park, CA (US) Photolabile Linkers: Substituent Effects on the Rates of Photochemi cal Cleavage.J. Org. Chem. 62(8): 2370-2380. (*) Notice: Subject to any disclaimer, the term of this Hu, Jun, et al. 2001. Competitive Photochemical Reactivity in a patent is extended or adjusted under 35 Self-Assembled Monolayer on a Colloidal Gold Cluster. J. Am. U.S.C. 154(b) by 365 days. Chem. Soc. 123(7): 1464-1470. Kessler, Martin, et al. 2003. Sequentially Photocleavable Protecting (21) Appl. No.: 11/341,041 Groups in Solid-Phase Synthesis. Org. Lett.5(8); 1179-1181. Kim, Hanyoung, et al. 2004. Core-Shell-Type Resins for Solid-Phase (22) Filed: Jan. 27, 2006 Peptide Synthesis: Comparison with Gel-Type Resins in Solid-Phase Photolytic Cleavage Reaction. Org. Lett. 6(19): 3273-3276. (65) Prior Publication Data Maxam, Allan M., et al. 1977. A new method for sequencing DNA. -
Peripheral Blood Cells Changes After Two Groups of Splenectomy And
ns erte ion p : O y p H e f Yunfu et al., J Hypertens (Los Angel) 2018, 7:1 n o l A a DOI: 10.4172/2167-1095.1000249 c c n r e u s o s J Journal of Hypertension: Open Access ISSN: 2167-1095 Research Article Open Access Peripheral Blood Cells Changes After Two Groups of Splenectomy and Prevention and Treatment of Postoperative Complication Yunfu Lv1*, Xiaoguang Gong1, XiaoYu Han1, Jie Deng1 and Yejuan Li2 1Department of General Surgery, Hainan Provincial People's Hospital, Haikou, China 2Department of Reproductive, Maternal and Child Care of Hainan Province, Haikou, China *Corresponding author: Yunfu Lv, Department of General Surgery, Hainan Provincial People's Hospital, Haikou 570311, China, Tel: 86-898-66528115; E-mail: [email protected] Received Date: January 31, 2018; Accepted Date: March 12, 2018; Published Date: March 15, 2018 Copyright: © 2018 Lv Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Objective: This study aimed to investigate the changes in peripheral blood cells after two groups of splenectomy in patients with traumatic rupture of the spleen and portal hypertension group, as well as causes and prevention and treatment of splenectomy related portal vein thrombosis. Methods: Clinical data from 109 patients with traumatic rupture of the spleen who underwent splenectomy in our hospital from January 2001 to August 2015 were retrospectively analyzed, and compared with those from 240 patients with splenomegaly due to cirrhotic portal hypertension who underwent splenectomy over the same period. -
Mediated Multidrug Resistance (MDR) in Cancer
A Thesis Entitled: Differential Effects of Dopamine D3 Receptor Antagonists in Modulating ABCG2 - Mediated Multidrug Resistance (MDR) in Cancer by Noor A. Hussein Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science in Pharmaceutical Sciences Degree in Pharmacology and Toxicology _________________________________________ Dr. Amit K. Tiwari, Committee Chair _________________________________________ Dr. Frank Hall , Committee Member _________________________________________ Dr. Zahoor Shah, Committee Member _________________________________________ Dr. Caren Steinmiller, Committee Member _________________________________________ Dr. Amanda Bryant-Friedrich, Dean College of Graduate Studies The University of Toledo May 2017 Copyright 2017, Noor A. Hussein This document is copyrighted material. Under copyright law, no parts of this document may be reproduced without the expressed permission of the author. An Abstract of Differential Effects of Dopamine D3 Receptor Antagonists in Modulating ABCG2 - Mediated Multidrug Resistance (MDR) by Noor A. Hussein Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science in Pharmaceutical Sciences Degree in Pharmacology and Toxicology The University of Toledo May 2017 The G2 subfamily of the ATP-binding cassette transporters (ABCG2), also known as the breast cancer resistance protein (BRCP), is an efflux transporter that plays an important role in protecting the cells against endogenous and exogenous toxic substances. The ABCG2 transporters are also highly expressed in the blood brain barrier (BBB), providing protection against specific toxic compounds. Unfortunately, their overexpression in cancer cells results in the development of multi-drug resistance (MDR), and thus, chemotherapy failure. Dopamine3 receptor (D3R) antagonists were shown to have excellent anti-addiction properties in preclinical animal models but produced limited clinical success with the lead molecule. -
Combined Effect of Granulocyte-Colony-Stimulating
J Korean Med. 2016;37(4):36-44 http://dx.doi.org/10.13048/jkm.16046 pISSN 1010-0695 • eISSN 2288-3339 Original Article Combined Effect of Granulocyte-Colony-Stimulating Factor-Induced Bone Marrow-Derived Stem Cells and Red Ginseng in Patients with Decompensated Liver Cirrhosis (Combined Effect of G-CSF and Red Ginseng in Liver Cirrhosis) Hyun Hee Kim1, Seung Mo Kim2, Kyung Soon Kim2, Min A Kwak2, Sang Gyung Kim3, Byung Seok Kim1, Chang Hyeong Lee1 1Department of Internal Medicine, Catholic University of Daegu School of Medicine 2Department of Internal Medicine, College of Korean Medicine, Daegu Haany University 3Department of Laboratory Medicine, Catholic University of Daegu School of Medicine Objectives: Granulocyte-colony-stimulating factor (G-CSF) mobilized bone marrow (BM)-derived hematopoietic stem cells could contribute to improvement of liver function. In addition, liver fibrosis can reportedly be prevented by the Rg 1 component of red ginseng. This study investigated the combined effect of G-CSF and red ginseng on decompensated liver cirrhosis. Methods: Four patients with decompensated liver cirrhosis were injected with G-CSF to proliferate BM stem cells for 4 days (5 μg/kg bid subcutaneously) and followed-up for 3 months. The patients also received red ginseng for 4 days (2 tablets tid per os). We analyzed Child-Pugh scores, Model for End-Stage Liver Disease (MELD) scores and cirrhotic complications. Results: All patients showed marked increases in White blood cell (WBC) and CD34+ cells in the peripheral blood, with a peak time of 4 days after G-CSF injection. Spleen size also increased after G-CSF injection, but not severely. -
Selective Toxicity of Rhodamine 123 in Carcinoma Cells in Vitro
[CANCER RESEARCH 43, 716-720, February 1983] 0008-5472/83/0043-0000502.00 Selective Toxicity of Rhodamine 123 in Carcinoma Cells in Vitro Theodore J. Lampidis, 1 Samuel D. Bernal, 2 lan C. Summerhayes, and Lan Bo Chen a Sidney Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115 ABSTRACT ing appears to be unique, since chemotherapeutic agents currently in clinical use have not been shown to be particularly The study of mitochondria in situ has recently been facilitated selective between tumorigenic and normal cells in vitro. through the use of rhodamine 123, a mitochondrial-specific fluorescent dye. It has been found to be nontoxic when applied MATERIALS AND METHODS for short periods to a variety of cell types and has thus become an invaluable tool for examining mitochondrial morphology and Cell Cultures. All cell types and cell lines were grown in Dulbecco's function in the intact living cell. In this report, however, we modified Eagle's medium supplemented with 10% calf serum (M. A. demonstrate that with continuous exposure, rhodamine 123 Bioproducts, Walkersville, Md.) at 37 ~ with 5% CO2. The following cell selectively kills carcinoma as compared to normal epithelial lines were obtained from the American Type Culture Collection: cells grown in vitro. At doses of rhodamine 123 which were CCL 105, CCL 15, CRL 1550, CRL 1420, CCL51, CCL77, CCL185, toxic to carcinoma cells, the conversion of mitochondrial-spe- CCL 34, PtK-1, CV-1, and BSC-I. The human bladder carcinoma line cific to cytoplasmic-nonspecific localization of the drug was (E J) was provided by Dr. -
Use of the Laser Dye Rhodamine 123
Status of Mitochondria in Living Human Fibroblasts during Growth and Senescence in Vitro : Use of the Laser Dye Rhodamine 123 SAMUEL GOLDSTEIN and LOUISE B . KORCZACK Departments of Medicine and Biochemistry, McMaster University Medical Center, Hamilton, Ontario, Canada L8N 3Z5. Dr. Goldstein's present address is : Departments of Medicine and Biochemistry, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205 Downloaded from ABSTRACT Rhodamine 123, a fluorescent laser dye that is selectively taken up into mitochondria of living cells, was used to examine mitochondrial morphology in early-passage (young), late- passage (old), and progeric human fibroblasts . Mitochondria were readily visualized in all cell types during growth (mid-log) and confluent stages . In all cell strains at confluence, mitochon- jcb.rupress.org dria became shorter, more randomly aligned, and developed a higher proportion of bead-like forms . Treatment of cells for six days with Tevenel, a chloramphenicol analog that inhibits mitochondrial protein synthesis, brought about a marked depletion of mitochondria and a diffuse background fluorescence . Cyanide produced a rapid release of preloaded mitochondria) fluorescence followed by detachment and killing of cells . Colcemid caused a random coiling on January 8, 2018 and fragmentation of mitochondria particularly in the confluent stage . No gross differences were discernible in mitochondria of the three cell strains in mid-log and confluent states or after these treatments . Butanol-extractable fluorescence after loading with rhodamine 123 was lower in all cell strains in confluent compared to mid-log stages . At confluence all three cell strains had similar rhodamine contents at zero-time and after washout up to 24 h . -
Factors Influencing Platelet Recovery After Blood Cell Transplantation in Multiple Myeloma
Bone Marrow Transplantation, (1997) 20, 375–380 1997 Stockton Press All rights reserved 0268–3369/97 $12.00 Factors influencing platelet recovery after blood cell transplantation in multiple myeloma MA Gertz1, MQ Lacy1, DJ Inwards1, AA Pineda2, MG Chen3, DA Gastineau1, A Tefferi1, RA Kyle1 and MR Litzow1 1Division of Hematology and Internal Medicine, 2Division of Transfusion Medicine, and 3Division of Radiation Oncology, Mayo Clinic and Mayo Foundation, Rochester, MN, USA Summary: cells result in durable engraftment after transplantation.2 Hematopoietic recovery can be accelerated by the use of We sought to determine factors that impact on the blood stem cells mobilized with growth factors or chemo- recovery of platelets after blood cell transplantation in therapy (or both). Hematopoietic recovery is more rapid patients with multiple myeloma. We performed retro- after mobilized peripheral blood stem cell transplantation spective analyses in 51 patients undergoing blood cell than after autologous bone marrow transplantation, and transplantation for multiple myeloma. The pro- hematopoietic recovery has been shown to be sustained, portional-hazards model was applied to determine sig- indicating that accessory cells found in the bone marrow nificant risk factors. Of 51 transplants, 14 patients failed are not required for durable engraftment.3 The more rapid to achieve a platelet count of 50 × 109/l. Median time to engraftment with mobilized stem cells is likely due to an a neutrophil count of 0.5 × 109/l was 10.5 days. Median increase in committed -
Antioxidants
antioxidants Article Insulin–Mimetic Dihydroxanthyletin-Type Coumarins from Angelica decursiva with Protein Tyrosine Phosphatase 1B and α-Glucosidase Inhibitory Activities and Docking Studies of Their Molecular Mechanisms Md Yousof Ali 1 , Susoma Jannat 2, Hyun Ah Jung 3,* and Jae Sue Choi 4,* 1 Department of Physiology and Pharmacology, Hotchkiss Brain Institute and Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada; [email protected] 2 Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB T2N 4N1, Canada; [email protected] 3 Department of Food Science and Human Nutrition, Jeonbuk National University, Jeonju 54896, Korea 4 Department of Food and Life Science, Pukyong National University, Busan 48513, Korea * Correspondence: [email protected] (H.A.J.); [email protected] (J.S.C.); Tel.: +82-63-270-4882 (H.A.J.); +82-51-629-7547 (J.S.C.) Abstract: As a traditional medicine, Angelica decursiva has been used for the treatment of many dis- eases. The goal of this study was to evaluate the potential of four natural major dihydroxanthyletin- type coumarins—(+)-trans-decursidinol, Pd-C-I, Pd-C-II, and Pd-C-III—to inhibit the enzymes, Citation: Ali, M.Y.; Jannat, S.; Jung, protein tyrosine phosphatase 1B (PTP1B) and α-glucosidase. In the kinetic study of the PTP1B H.A.; Choi, J.S. Insulin–Mimetic enzyme’s inhibition, we found that (+)-trans-decursidinol, Pd-C-I, and Pd-C-II led to competitive Dihydroxanthyletin-Type Coumarins inhibition, while Pd-C-III displayed mixed-type inhibition. Moreover, (+)-trans-decursidinol exhib- from Angelica decursiva with Protein ited competitive-type, and Pd-C-I and Pd-C-II mixed-type, while Pd-C-III showed non-competitive Tyrosine Phosphatase 1B and type inhibition of α-glucosidase. -
Blood Lab First Week
Blood Lab First Week This is a self propelled powerpoint study atlas of blood cells encountered in examination of the peripheral blood smear. It is a requirement of this course that you begin review of these slides with the first day of class in order to familiarize yourself with terms used in describing peripheral blood morphology. Laboratory final exam questions are derived directly from these slides. The content of these slides may duplicate slides (1-37) listed on the Hematopathology Website. You must familiarize yourself with both sets of slides in order to have the best learning opportunity. Before Beginning This Slide Review • Please read the Laboratory information PDF under Laboratory Resources file to learn about – Preparation of a blood smear – How to select an area of the blood smear for review of morphology and how to perform a white blood cell differential – Platelet estimation – RBC morphology descriptors • Anisocytosis • Poikilocytosis • Hypochromia • Polychromatophilia Normal blood smear. Red blood cells display normal orange pink cytoplasm with central pallor 1/3-1/2 the diameter of the red cell. There is mild variation in size (anisocytosis) but no real variation in shape (poikilocytosis). To the left is a lymphocyte. To the right is a typical neutrophil with the usual 3 segmentations of the nucleus. Med. Utah pathology Normal blood: thin area Ref 2 Normal peripheral blood smear. This field is good for exam of cell morphology, although there are a few minor areas of overlap of red cells. Note that most cells are well dispersed and the normal red blood cell central pallor is noted throughout the smear. -
Mitochondrial Dynamics Quantitatively Revealed by STED Nanoscopy with an Enhanced Squaraine Variant Probe
Supplementary Information Mitochondrial dynamics quantitatively revealed by STED nanoscopy with an enhanced squaraine variant probe Xusan Yang1,3, Ɨ, Zhigang Yang2, Ɨ, *, Ying He2, Chunyan Shan4, Wei Yan2, Zhaoyang Wu1, Peiyuan Chai4, Junlin Teng4, Junle Qu2, *, Peng Xi1, * 1 Department of biomedical engineering, College of engineering, Peking University, Beijing, 100871, China 2 Key laboratory of optoelectronic devices and systems of ministry of education and Guangdong province, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen, 518060, China 3 School of applied and engineering physics, Cornell University, Ithaca, 14853, United States 4 School of life Sciences, Peking University, Beijing, 100871, China *Email: [email protected], [email protected], [email protected], [email protected] Ɨ These authors contributed equally to this work Supplementary Figures Supplementary Figure 1 Co-localization experiment employing MitoTracker Green (Rhodamine 123) as golden standard for mitochondrial marker. The first column, DIC image; the second column, ER- Lyso- and Mito-Tracker green labeled HeLa cells; c, g the third column, enhanced squaraine dye labeled HeLa cells; the fourth column, merged images; the fifth column, Pearson’s coefficients, excitation wavelength: Rhodamine 123, Lyso- and ER- trackers (488 nm), MitoESq-635 (633 -nm), detect range of Rhodamine 123 Lyso- and ER-trackers (500-560 nm); MitoESq-635 (640-800 nm), Scale bar, 10 μm. From Supplementary Figure 1-3, it can be demonstrated that MitoESq-635 can preferentially target for mitochondria in live cells. HeLa cells were subjected to incubating with Mito-, Lyso-, ER- trackers and MitoESq-635, respectively. From the confocal imaging results obtained by a Leica SP8 confocal Laser scanning microscope, the probe revealed the best overlapping imaging with Mitotracker (Rho123).